The Influence of Angiopoietin-like Protein 3 on Macrophages Polarization and Its Effect on the Podocyte EMT in Diabetic Nephropathy

Overview

Journal Front Immunol

Specialty Allergy & Immunology

Date 2023 Aug 28

PMID 37638046

Authors

Yanli Ma

Yu Chen

Hong Xu

Ni Du

Affiliations

Soon will be listed here.

Abstract

Background: Podocyte injury, which involves the podocyte epithelial-mesenchymal transition (EMT) process, is a crucial factor contributing to the progression of diabetic nephropathy (DN) and proteinuria. Our study aimed to examine the protective properties of Angiopoietin-like protein 3 (Angptl3) knockout on podocyte damage and macrophage polarization in DN mice and podocytes treated with HG. Furthermore, we also sought to investigate the underlying molecular mechanism responsible for these effects.

Methods: DN was induced in B6;129S5 mice through intraperitoneal injection of 40 mg/kg of streptozotocin (STZ). Subsequently, the changes in renal function, podocyte apoptosis, inflammatory factors (tumor necrosis factor-α [TNF-α], interleukin-6 [IL-6], and interleukin-1β [IL-1β]), IL-10, TGF-β1, IL-1Ra, IL-10Ra, and nephrin were evaluated. Moreover, we investigated the mechanism underlying the role of Angptl3 in macrophages polarization, podocyte injury, podocyte EMT.

Results: Our findings revealed that Angptl3 knockout significantly attenuated STZ or HG-induced renal dysfunction and podocyte EMT. In both and studies, Angptl3 knockout led to (1) promote the transformation of M1 type macrophages into M2 type macrophages; (2) amelioration of the reduced expression of nephrin, synaptopodin, and podocin; (3) inhibition of NLRP3 inflammasome activation and release of IL-1β; and (4) regulation of α-SMA expression via the macrophage polarization. (5) After HG treatment, there was an increase in pro-inflammatory factors and foot cell damage. These changes were reversed upon Angptle knockdown.

Conclusion: Our study suggests that the knockout of Angptl3 alleviates podocyte EMT and podocyte injury by regulating macrophage polarization.

Citing Articles

Genetic association analysis of lipid-lowering drug target genes in chronic kidney disease.

Zhang Y, Ou G, Peng L, Pan J, Zhang S, Shi J Front Endocrinol (Lausanne). 2025; 15:1434145.

PMID: 39877840 PMC: 11772207. DOI: 10.3389/fendo.2024.1434145.

Angiopoietin-like protein 4 dysregulation in kidney diseases: a promising biomarker and therapeutic target.

Li Y, Zhang Y, Cao M, Yuan T, Ou S Front Pharmacol. 2025; 15():1475198.

PMID: 39840089 PMC: 11747783. DOI: 10.3389/fphar.2024.1475198.

Human umbilical cord mesenchymal stem cell-derived exosomes mitigate diabetic nephropathy via enhancing M2 macrophages polarization.

Li X, Chen M, Cao J, Chen X, Song H, Shi S Heliyon. 2024; 10(17):e37002.

PMID: 39286156 PMC: 11402917. DOI: 10.1016/j.heliyon.2024.e37002.

Shionone Inhibits Glomerular Fibirosis by Suppressing NLRP3 Related Inflammasome though SESN2-NRF2/ HO-1 Pathway.

Xiao T, Zhao H, Wang Y, Chen M, Wang C, Qiao C Diabetes Metab J. 2024; 49(1):34-48.

PMID: 39192821 PMC: 11788555. DOI: 10.4093/dmj.2024.0024.

The Pleiotropic Effects of Lipid-Modifying Interventions: Exploring Traditional and Emerging Hypolipidemic Therapies.

Kounatidis D, Tentolouris N, Vallianou N, Mourouzis I, Karampela I, Stratigou T Metabolites. 2024; 14(7).

PMID: 39057711 PMC: 11278853. DOI: 10.3390/metabo14070388.

References

Wu X, Zhang H, Qi W, Zhang Y, Li J, Li Z . Nicotine promotes atherosclerosis via ROS-NLRP3-mediated endothelial cell pyroptosis. Cell Death Dis. 2018; 9(2):171. PMC: 5833729. DOI: 10.1038/s41419-017-0257-3. View

Tesch G, Allen T . Rodent models of streptozotocin-induced diabetic nephropathy. Nephrology (Carlton). 2007; 12(3):261-6. DOI: 10.1111/j.1440-1797.2007.00796.x. View

Minicocci I, Montali A, Robciuc M, Quagliarini F, Censi V, Labbadia G . Mutations in the ANGPTL3 gene and familial combined hypolipidemia: a clinical and biochemical characterization. J Clin Endocrinol Metab. 2012; 97(7):E1266-75. PMC: 5393441. DOI: 10.1210/jc.2012-1298. View

Tan A, Forbes J, Cooper M . AGE, RAGE, and ROS in diabetic nephropathy. Semin Nephrol. 2007; 27(2):130-43. DOI: 10.1016/j.semnephrol.2007.01.006. View

Kang M, Kim S, Oh S, Na W, Kang Y . Tangeretin Ameliorates Glucose-Induced Podocyte Injury through Blocking Epithelial to Mesenchymal Transition Caused by Oxidative Stress and Hypoxia. Int J Mol Sci. 2020; 21(22). PMC: 7697471. DOI: 10.3390/ijms21228577. View

Flyvbjerg A . The role of the complement system in diabetic nephropathy. Nat Rev Nephrol. 2017; 13(5):311-318. DOI: 10.1038/nrneph.2017.31. View

Musunuru K, Pirruccello J, Do R, Peloso G, Guiducci C, Sougnez C . Exome sequencing, ANGPTL3 mutations, and familial combined hypolipidemia. N Engl J Med. 2010; 363(23):2220-7. PMC: 3008575. DOI: 10.1056/NEJMoa1002926. View

Elliott E, Sutterwala F . Initiation and perpetuation of NLRP3 inflammasome activation and assembly. Immunol Rev. 2015; 265(1):35-52. PMC: 4400874. DOI: 10.1111/imr.12286. View

Schmidt J, Rattner D, Lewandrowski K, Compton C, Mandavilli U, Knoefel W . A better model of acute pancreatitis for evaluating therapy. Ann Surg. 1992; 215(1):44-56. PMC: 1242369. DOI: 10.1097/00000658-199201000-00007. View

10.

Stieger N, Worthmann K, Teng B, Engeli S, Das A, Haller H . Impact of high glucose and transforming growth factor-β on bioenergetic profiles in podocytes. Metabolism. 2012; 61(8):1073-86. DOI: 10.1016/j.metabol.2011.12.003. View

11.

Qiu Y, Tang L . Roles of the NLRP3 inflammasome in the pathogenesis of diabetic nephropathy. Pharmacol Res. 2016; 114:251-264. DOI: 10.1016/j.phrs.2016.11.004. View

12.

Locati M, Curtale G, Mantovani A . Diversity, Mechanisms, and Significance of Macrophage Plasticity. Annu Rev Pathol. 2019; 15:123-147. PMC: 7176483. DOI: 10.1146/annurev-pathmechdis-012418-012718. View

13.

Xiang E, Han B, Zhang Q, Rao W, Wang Z, Chang C . Human umbilical cord-derived mesenchymal stem cells prevent the progression of early diabetic nephropathy through inhibiting inflammation and fibrosis. Stem Cell Res Ther. 2020; 11(1):336. PMC: 7397631. DOI: 10.1186/s13287-020-01852-y. View

14.

Tang D, Kang R, Vanden Berghe T, Vandenabeele P, Kroemer G . The molecular machinery of regulated cell death. Cell Res. 2019; 29(5):347-364. PMC: 6796845. DOI: 10.1038/s41422-019-0164-5. View

15.

Calle P, Hotter G . Macrophage Phenotype and Fibrosis in Diabetic Nephropathy. Int J Mol Sci. 2020; 21(8). PMC: 7215738. DOI: 10.3390/ijms21082806. View

16.

Ma Y, Liu J, Liu H, Han X, Sun L, Xu H . Podocyte protection by Angptl3 knockout via inhibiting ROS/GRP78 pathway in LPS-induced acute kidney injury. Int Immunopharmacol. 2022; 105:108549. DOI: 10.1016/j.intimp.2022.108549. View

17.

Wu M, Yang Z, Zhang C, Shi Y, Han W, Song S . Inhibition of NLRP3 inflammasome ameliorates podocyte damage by suppressing lipid accumulation in diabetic nephropathy. Metabolism. 2021; 118:154748. DOI: 10.1016/j.metabol.2021.154748. View

18.

Wada J, Makino H . Innate immunity in diabetes and diabetic nephropathy. Nat Rev Nephrol. 2015; 12(1):13-26. DOI: 10.1038/nrneph.2015.175. View

19.

Wu M, Han W, Song S, Du Y, Liu C, Chen N . NLRP3 deficiency ameliorates renal inflammation and fibrosis in diabetic mice. Mol Cell Endocrinol. 2018; 478:115-125. DOI: 10.1016/j.mce.2018.08.002. View

20.

Bussolati B, Deregibus M, Fonsato V, Doublier S, Spatola T, Procida S . Statins prevent oxidized LDL-induced injury of glomerular podocytes by activating the phosphatidylinositol 3-kinase/AKT-signaling pathway. J Am Soc Nephrol. 2005; 16(7):1936-47. DOI: 10.1681/ASN.2004080629. View